$14.87
-0.56[-3.63%]
Last update: 10:14AM Get Real Time Here
Arcus Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | PM | RCUS | Q1 | -$1.09 | -$0.90 | — | — | $25.00M | $37.32M | — | — | Get Alert |
02/21/2024 | PM | RCUS | Q4 | -$0.93 | -$1.02 | -$1.08 | -5.88% | $34.00M | $28.37M | $31.00M | 9.27% | Get Alert |
11/07/2023 | PM | RCUS | Q3 | -$0.90 | -$1.14 | -$0.94 | 17.54% | $33.58M | $27.28M | $32.00M | 17.30% | Get Alert |
08/07/2023 | AM | RCUS | Q2 | -$0.93 | -$1.00 | -$1.04 | -4.00% | $26.76M | $35.86M | $29.00M | -19.13% | Get Alert |
05/09/2023 | PM | RCUS | Q1 | -$0.96 | -$1.16 | -$1.09 | 6.03% | $18.00M | $24.97M | $25.00M | 0.12% | Get Alert |
02/28/2023 | PM | RCUS | Q4 | $3.71 | -$1.07 | -$0.93 | 13.08% | $354.50M | $23.31M | $34.00M | 45.86% | Get Alert |
11/02/2022 | PM | RCUS | Q3 | -$1.11 | -$1.04 | -$0.90 | 13.46% | $9.46M | $21.89M | $33.58M | 53.41% | Get Alert |
08/03/2022 | PM | RCUS | Q2 | -$1.09 | -$0.94 | -$0.93 | 1.06% | $9.46M | $21.12M | $26.76M | 26.70% | Get Alert |
05/09/2022 | PM | RCUS | Q1 | -$1.08 | -$0.31 | -$0.96 | -209.68% | $9.46M | $79.42M | $18.00M | -77.33% | Get Alert |
02/23/2022 | PM | RCUS | Q4 | -$0.82 | -$0.74 | $3.71 | 601.35% | $9.49M | $39.39M | $354.50M | 799.97% | Get Alert |
11/08/2021 | PM | RCUS | Q3 | $0.03 | -$1.08 | -$1.11 | -2.78% | $64.53M | $9.40M | $9.46M | 0.65% | Get Alert |
08/05/2021 | PM | RCUS | Q2 | -$0.93 | -$0.88 | -$1.09 | -23.86% | $1.75M | $13.05M | $9.46M | -27.50% | Get Alert |
05/05/2021 | PM | RCUS | Q1 | -$0.63 | -$0.84 | -$1.08 | -28.57% | $1.75M | $13.34M | $9.46M | -29.08% | Get Alert |
02/24/2021 | PM | RCUS | Q4 | -$0.38 | -$0.75 | -$0.82 | -9.33% | $9.75M | $7.93M | $9.49M | 19.63% | Get Alert |
11/05/2020 | PM | RCUS | Q3 | -$0.51 | $0.05 | $0.03 | -40.00% | $1.75M | $48.15M | $64.53M | 34.02% | Get Alert |
08/06/2020 | PM | RCUS | Q2 | -$0.64 | — | -$0.93 | — | $1.75M | — | $1.75M | — | Get Alert |
05/05/2020 | PM | RCUS | Q1 | -$0.41 | — | -$0.63 | — | $1.75M | — | $1.75M | — | Get Alert |
03/05/2020 | PM | RCUS | Q4 | -$0.28 | — | -$0.38 | — | $1.56M | — | $9.75M | — | Get Alert |
11/05/2019 | PM | RCUS | Q3 | -$0.25 | — | -$0.51 | — | $4.29M | — | $1.75M | — | Get Alert |
Arcus Biosciences (RCUS) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 21, 2024 for Q4.
The Actual EPS was $-1.08, which missed the estimate of $-1.02.
The Actual Revenue was $31M, which beat the estimate of $28.4M.
Browse earnings estimates, EPS, and revenue on all stocks.